multiforme,'8 or Ehlers-Danlos syndrome. '9 Nevertheless, such diagnostic problems rarely present much difficulty. More often the crux of the matter is to decide whether demonstrable trauma was caused by accident or not. Inevitably mistakes will be made in both directions. The case conference with all relevant professional workers, including doctors, nurses, social workers, health visitors, nursery staff, and often police, is aimed at serving the best interests of the child, sharing the burden of professional responsibility, and trying to minimise the scope for error; but where serious doubt remains after full consultation and there is concern for the safety ofthe child the ultimate arbiter must be society as a whole as represented in a court of law.
Child abuse has a twofold relation with cerebral palsy: brain damage may be the consequence or the precursor of inflicted injury. Among 86 children with cerebral palsy attending one centre in a deprived area ofChicago there were eight whose brain damage resulted from abuse and eight who were abused after the diagnosis of cerebral palsy was made."
A further 12 were thought to be at serious risk ofabuse. Such figures cannot be taken to be representative. In Liverpool physical abuse appeared to be much less common both before and after the diagnosis of cerebral palsy,2' but paediatricians should try to practise prevention by providing help which is readily available when needed for the parents of young children.22
The outcome for children who have been seriously abused is often poor. In a socially deprived inner city area of Liverpool 50 children were taken into the care of the local authority after being abused. Twenty five of them were later returned to their parents, and the outcome was considered satisfactory in seven.23 Five suffered further abuse. In the 25 who were not returned to their parents the outcome was thought to be satisfactory in 17. Factors tending to an unsatisfactory outcome were increasing age when first taken into care, increasing length oftime in care before returning to the parents, and multiple placements while in care. The children who did best were those for whom an early decision was made to sever contact with the parents and to place the child with a substitute family.
No controls were used in the Liverpool study, but an Australian study compared the personality development of abused children with that of controls matched for age, sex, ethnic group, and social class.24When examined several years after the abuse the study children were found to have fewer friends, less ambition, lower selfesteem, and more behaviour disturbance than the controls. The personality traits of abused children justify concern about their development of parenting skills when they reach adulthood-and the likely repetition of the cycle ofdeprivation and abuse. Professional itervention must be aimed at breaking this cycle. Ketoconazole: a reappraisal
The recent letter from the chairman of the Committee on the Safety ofMedicines to doctors in Britain about oral ketoconazole and hepatotoxicity has aroused widespread concern. This imidazole antifungal drug is available for both oral and topical use and so has wide potential clinical applications. Serious adverse effects have been rare, though symptoms such as gynaecomastia related to androgen blocking activity' and anaphylaxis have been reported in addition to hepatotoxicity. 2 The effect of ketoconazole on the liver ranges from asymptomatic transient abnormalities of the enzyme activities to potentially fatal acute hepatic necrosis.3 In view of these findings clearly the risks of using the drug need to be weighed against the likely benefits to the patient. For Risk of leukaemia associated with cancer chemotherapy
The objectives of the treatment of cancer must be to restore a good quality oflife and when possible cure. The experienced clinician should be able to weigh the risks of temporary morbidity associated with a particular treatment against the prospect of achieving these objectives. As the results of treatment improve and survival is prolonged new clinical events may become manifest in association either with the disease or with its treatment. When this happens the late effects of treatment must be distinguished from those of the disease itself. Potentially one of the most serious late events is the induction of a second cancer. An association between the administration of arsenic and the development of squamous cell carcinoma was recognised a century ago, and in the late 1940s an antineoplastic drug was shown to have carcinogenic properties.' Of the various classes of anticancer drugs the alkylating agents, which so effectively damage DNA, might be expected to induce malignant change in a predictable fashion. Proving this suspicion conclusively and in a way that might usefully modify clinical practice has been a difficult and lengthy exercise. Plainly the problem is not substantial, for despite the widespread use of chemotherapy second cancers are rare (though this may partly reflect the limited survival ofmany ofthose treated). When second malignancies do occur the epidemiologist might reasonably argue that these may be spontaneous in patients with an increased tendency to malignant change. Both features might be expected to be more apparent in patients whose survival is increased. At present measurement of the risk of malignancy induced by treatment depends on the relation between the observed number ofcases and those which might be expected for the population studied. Identifying this denominator is a weak link in the calculation but one that may be strengthened by comparing different types of populations theoretically at risk.
Exposure to radiation might be regarded as the benchmark for comparison. The Japanese populations exposed to whole body irradiation from the atomic bombs showed an increase in acute non-lymphoblastic leukaemia after some years and in solid tumours after a much longer latent period. For this type of exposure a dose relation may be identified, whereas that resulting from high dose fractionated irradiation is much more haphazard. The relation between exposure to radiation and the induction of cancer is highly complex, so that comparisons with exposure to radiation may not be appropriate or helpful in understanding the risks of leukaemia induced by chemotherapy.2
The mechanism ofinduction ofmalignant change is almost certainly unrelated to immunosuppression even though the incidence of some types of malignant tumours does increase in patients who are immunosuppressed (by whatever means).3 Acute non-lymphoblastic leukaemia features only rarely among the resulting tumours.
Retrospective analyses of patients with cancer who have received different permutations oftreatments indicate that in some groups the incidence of acute non-lymphoblastic leukaemia seems to be increased above that expected. The problems of relating this to treatment should not be underestimated, but a certain consistency in outcome is apparent among the surveys from different centres. An increased incidence (observed over expected) has been seen in patients
